Publications by authors named "Suah Yang"

Claim this Profile
P
Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy.
Youngjoo Lee, Sukyung Song, Suah Yang, Jinseong Kim, Yujeong Moon

Acta Pharm Sin B· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy.
Sukyung Song, Man Kyu Shim, Suah Yang, Jaewan Lee, Wan Su Yun

Bioact Mater· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity.
Suah Yang, Man Kyu Shim, Sukyung Song, Hanhee Cho, Jiwoong Choi

Biomaterials· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy.
Nayeon Shim, Seong Ik Jeon, Suah Yang, Jung Yeon Park, Mihee Jo

Biomaterials· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity.
Man Kyu Shim, Suah Yang, Jooho Park, Jun Sik Yoon, Jinseong Kim

J Nanobiotechnology· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light.
Jiwoong Choi, Il Seong Lee, Ju Seung Lee, Sangmin Jeon, Wan Su Yun, Suah Yang

Biomater Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy.
Wan Su Yun, Man Kyu Shim, Seungho Lim, Sukyung Song, Jinseong Kim, Suah Yang

Nanomaterials (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery.
Man Kyu Shim, Suah Yang, In-Cheol Sun, Kwangmeyung Kim

Adv Drug Deliv Rev· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death.
Yujeong Moon, Man Kyu Shim, Jiwoong Choi, Suah Yang, Jinseong Kim

Theranostics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses.
Jeongrae Kim, Yongwhan Choi, Suah Yang, Jaewan Lee, Jiwoong Choi

Pharmaceutics· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy.
Hanhee Cho, Man Kyu Shim, Suah Yang, Sukyung Song, Yujeong Moon

Pharmaceutics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy.
Jiwoong Choi, Man Kyu Shim, Suah Yang, Hee Sook Hwang, Hanhee Cho

ACS Nano· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.
Suah Yang, Man Kyu Shim, Woo Jun Kim, Jiwoong Choi, Gi-Hoon Nam

Biomaterials· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Suah Yang, In-Cheol Sun, Hee Sook Hwang, Man Kyu Shim, Hong Yeol Yoon

J Mater Chem B· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance.
Jinseong Kim, Man Kyu Shim, Suah Yang, Yujeong Moon, Sukyung Song

J Control Release· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular tomography.
Seungho Lim, Hong Yeol Yoon, Soon-Jung Park, Sukyung Song, Man Kyu Shim, Suah Yang

Biomaterials· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug.
Han Young Kim, Sang Hoon Um, Yejin Sung, Man Kyu Shim, Suah Yang

J Control Release· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy.
Man Kyu Shim, Yujeong Moon, Suah Yang, Jinseong Kim, Hanhee Cho

Biomaterials· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death.
Yongwhan Choi, Hong Yeol Yoon, Jeongrae Kim, Suah Yang, Jaewan Lee

Pharmaceutics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Situ One-Step Fluorescence Labeling Strategy of Exosomes via Bioorthogonal Click Chemistry for Real-Time Exosome Tracking In Vitro and In Vivo.
Sukyung Song, Man Kyu Shim, Seungho Lim, Yujeong Moon, Suah Yang

Bioconjug Chem· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Necroptosis-Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy.
Wooram Um, Hyewon Ko, Dong Gil You, Seungho Lim, Gijung Kwak, Suah Yang

Adv Mater· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis